
Cambridge Nutritional Sciences plc
(the 'Company' or 'CNS')
Director/PDMR Shareholding
CNS (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that it has received notification that Carolyn Rand, Non-Executive Chair of the Company, has purchased 97,500 ordinary shares of 4 pence each in the Company ("Ordinary Shares") on 29 January 2025, at a price of 3.668 pence each.
A summary of Carolyn Rand's resultant holdings is below:
Director | Board Position | Number of Ordinary Shares acquired | Total beneficial holding of Ordinary Shares following this acquisition | |
Number of Ordinary Shares | Approximate % of Company's issued share capital | |||
Carolyn Rand | Non-Executive Chair | 97,500 | 97,500 | 0.04% |
Contacts:
Cambridge Nutritional Sciences plc | ||||
Carolyn Rand, Non-Executive Chair | | |||
James Cooper, Interim Chief Executive | | |||
| | |||
Cavendish Capital Markets Limited | Tel: 020 7220 0500 | |||
Geoff Nash / Edward Whiley (Corporate Finance) | | |||
Nigel Birks / Harriet Ward (ECM) | | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | | | |
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.
Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a) | Name
| Carolyn Rand | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Non-Executive Chair | ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Cambridge Nutritional Sciences plc | ||||
b)
| LEI
| 2138007U9P4BTZTYIR92 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 4 pence each
ISIN: GB00B1VCP282 | ||||
b)
| Nature of the transaction
| Ordinary Shares purchased | ||||
c) | Price(s) and volume(s) |
| ||||
d)
| Aggregated information
-Aggregated volume
- Price
| See above | ||||
e)
| Date of the transaction | 29.01.2025 | ||||
f)
| Place of the transaction | London Stock Exchange |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.